NYSE · MTD
Healthcare · Medical - Diagnostics & Research
$1,392.32
Down-$18.12 (-1.28%)
Updated Sep 20, 2026, 2:26 PM
SID Score
5.2/10
Composite research score
Smart Money
58/100
Neutral
Price performance
1M range · 19 trading sessions · Daily adjusted prices
MTD closed at $1,392.32 after 19 trading sessions, down 0.47% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | $1,404.82 | $1,415.63 | $1,385.125 | $1,392.32 | 544.55K |
| Sep 17, 2026 | $1,401.12 | $1,423.42 | $1,380.44 | $1,410.44 | 288.01K |
| Sep 16, 2026 | $1,337.56 | $1,400.08 | $1,331.235 | $1,378.69 | 355.61K |
| Sep 15, 2026 | $1,293.46 | $1,335.84 | $1,284.7254 | $1,330.40 | 211.75K |
| Sep 14, 2026 | $1,302.88 | $1,306.14 | $1,274.51 | $1,285.75 | 206K |
| Sep 11, 2026 | $1,294.03 | $1,302.845 | $1,286.66 | $1,293.52 | 96.7K |
| Sep 10, 2026 | $1,275.79 | $1,296.6461 | $1,266.55 | $1,280.58 | 185.9K |
| Sep 9, 2026 | $1,303.57 | $1,316.39 | $1,288.84 | $1,290.36 | 193.68K |
| Sep 8, 2026 | $1,331.81 | $1,347.85 | $1,322.92 | $1,325.52 | 151.12K |
| Sep 4, 2026 | $1,341.57 | $1,358.78 | $1,339.09 | $1,345.26 | 103.03K |
| Sep 3, 2026 | $1,376.16 | $1,387.32 | $1,334.73 | $1,356.23 | 168.38K |
| Sep 2, 2026 | $1,361.36 | $1,398.13 | $1,357.19 | $1,367.74 | 178.97K |
| Sep 1, 2026 | $1,410.75 | $1,415.00 | $1,370.33 | $1,375.96 | 168.55K |
| Aug 31, 2026 | $1,384.20 | $1,407.11 | $1,376.235 | $1,405.14 | 221.17K |
| Aug 28, 2026 | $1,401.09 | $1,406.925 | $1,391.6171 | $1,398.58 | 202.02K |
| Aug 27, 2026 | $1,406.36 | $1,440.22 | $1,400.61 | $1,407.43 | 146.07K |
| Aug 26, 2026 | $1,392.11 | $1,413.406 | $1,390.81 | $1,398.46 | 97.13K |
| Aug 25, 2026 | $1,413.57 | $1,421.775 | $1,395.985 | $1,402.25 | 116.92K |
| Aug 24, 2026 | $1,393.48 | $1,419.10 | $1,385.675 | $1,398.89 | 164.4K |
The latest Smart Investors Daily articles mentioning MTD.
MTD research
Company profile and research snapshot.
Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 28%, China about 16% and the rest of the world about 19%.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 2, 2026 | Rothschild & Co | Sell | — |
| Sep 1, 2026 | RBC Capital | Sector Perform | — |
| Aug 4, 2026 | Morgan Stanley | Equal-Weight | — |
| Aug 3, 2026 | Evercore ISI Group | Outperform | — |
| Aug 3, 2026 | Wells Fargo | Equal-Weight | — |
No generated briefing is available yet.
Benzinga · Sep 17, 2026
Mettler-Toledo Intl (NYSE:MTD) has outperformed the market over the past 20 years by 7.54% on an annualized basis producing an average annual return of 16.64%. Currently, Mettler-Toledo Intl has a market capitalization
Yahoo · Sep 16, 2026
Weitz Investment Management, an investment management firm, released its second-quarter Q2 2026 investor letter for the “Multi Cap Equity Fund”. The letter can be downloaded here. The Multi Cap Equity Fund’s Institutional Class returned 7.90% in Q2, underperforming the Bloomberg U.S. 3000 Index’s 15.71% gain. Markets rose in the quarter on hopes of de-escalating Middle East […]
Yahoo · Sep 15, 2026
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, “Your margin is my opportunity”.
Yahoo · Sep 14, 2026
Mettler-Toledo has lagged behind the Nasdaq Composite over the past year, and analysts remain moderately bullish about the stock’s outlook.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning MTD.
